3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Endocrine
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
64
Neoplasms
37
Colorectal Neoplasms
35
Neoplasm Metastasis
32
Breast Neoplasms
31
Ovarian Neoplasms
28
Prostatic Neoplasms
27
Pancreatic Neoplasms
27
Recurrence
26
Multiple Myeloma
25
Melanoma
24
Squamous Cell Carcinoma of Head and Neck
23
Glioblastoma
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lung Neoplasms
18
Endometrial Neoplasms
18
Triple Negative Breast Neoplasms
17
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma, Non-Hodgkin
15
Stomach Neoplasms
14
Leukemia, Myeloid, Acute
14
Colonic Neoplasms
14
Burkitt Lymphoma
14
Carcinoma, Renal Cell
13
Small Cell Lung Carcinoma
12
Glioma
12
Uterine Cervical Neoplasms
11
Sarcoma
11
Lymphoma
11
Head and Neck Neoplasms
11
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Adrenal Gland Neoplasms
×
30 days
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled